Search results for "temi"

showing 10 items of 3194 documents

Internal Simulation of an Agent’s Intentions

2013

We present the Associative Self-Organizing Map (A-SOM) and propose that it could be used to predict an agent’s intentions by internally simulating the behaviour likely to follow initial movements. The A-SOM is a neural network that develops a representation of its input space without supervision, while simultaneously learning to associate its activity with an arbitrary number of additional (possibly delayed) inputs. We argue that the A-SOM would be suitable for the prediction of the likely continuation of the perceived behaviour of an agent by learning to associate activity patterns over time, and thus a way to read its intentions.

Associative Self-Organizing Map; Internal Simulation;ContinuationArtificial neural networkbusiness.industryComputer scienceAssociative Self-Organizing MapRepresentation (systemics)Artificial intelligenceSpace (commercial competition)businessInternal SimulationAssociative property
researchProduct

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

2022

Background: The combination of atezolizumab-bevacizumab has been proven to be superior to sorafenib for the treatment of unresectable hepatocellular carcinoma not amenable to locoregional treatments, be-coming the standard of care of systemic therapy.Aim: This study aimed at assessing real-world feasibility of atezolizumab-bevacizumab in patients treated with tyrosine-kinase inhibitors.Methods: Among 1447 patients treated with tyrosine-kinase inhibitors from January 2010 to December 2020, we assessed the percentage of those potentially eligible to atezolizumab-bevacizumab (according to IMbrave-150 trial criteria), and the overall survival of eligible and non-eligible patients.Results: 422 (…

Atezolizumab-bevacizumabClinical Trials as TopicAntineoplastic Combined Chemotherapy ProtocolCarcinoma HepatocellularSystemic therapyHepatologyHepatocellular carcinomaTirosin-kinase inhibitorLiver NeoplasmsGastroenterologyTirosin-kinase inhibitor.Atezolizumab-bevacizumab; Hepatocellular carcinoma; Systemic therapy; Tirosin-kinase inhibitorBevacizumabFeasibility StudieTyrosineHumanDigestive and Liver Disease
researchProduct

Awareness and Partitional Informational Structures

1997

We begin with an example to motivate the introduction of the concept of unawareness in models of information. There are a subject and two possible states of the world, σ and τ. At σ a certain fact p happens — it is true — and the subject sees it or hears it or anyhow perceives it, so that he knows it is true (in Geanakoplos [5] the subject is Sherlock Holmes’ assistant and fact p is ‘the dog barks’). At state τ fact p does not occur (it is false), and the subject not only does not see it or hear it etc.; but what is more, he does not even think of the possibility that it might: fact p is not present to the subject’s mind. What is an appropriate formal model for this story?

Atomic sentenceEpistemic modal logicbusiness.industryCanonical modelSubject (philosophy)Modal logicState (computer science)Artificial intelligenceRule of inferencePsychologybusinessEpistemology
researchProduct

Fuzzy Fusion in Multimodal Biometric Systems

2007

Multimodal authentication systems represent an emerging trend for information security. These systems could replace conventional mono-modal biometric methods using two or more features for robust biometric authentication tasks. They employ unique combinations of measurable physical characteristics: fingerprint, facial features, iris of the eye, voice print, hand geometry, vein patterns, and so on. Since these traits are hardly imitable by other persons, the aim of these multibiometric systems is to achieve a high reliability to determine or verify person's identity. In this paper a multimodal biometric system using two different fingerprints is proposed. The matching module integrates fuzzy…

AuthenticationBiometricsComputational geometryData fusionFeature extractionSecurity of dataSettore ING-INF/05 - Sistemi Di Elaborazione Delle Informazioni
researchProduct

Genetics and novel aspects of therapies in systemic lupus erythematosus.

2015

Autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, autoimmune hepatitis and inflammatory bowel disease, have complex pathogeneses and the factors which cause these disorders are not well understood. But all have in common that they arise from a dysfunction of the immune system, interpreting self components as foreign antigens. Systemic lupus erythematosus (SLE) is one of these complex inflammatory disorders that mainly affects women and can lead to inflammation and severe damage of virtually any tissue and organ. Recently, the application of advanced techniques of genome-wide scanning revealed more genetic information about SLE than previously possible. These case-contro…

Autoimmune diseaseMultiple sclerosisImmunologyGenome-wide association studyAutoimmune hepatitisBiologymedicine.diseaseInflammatory bowel diseaseImmune systemAutologous stem-cell transplantationTreatment OutcomeRheumatoid arthritisHistocompatibility AntigensImmunologymedicineImmunology and AllergyAnimalsHumansLupus Erythematosus SystemicGenetic Predisposition to Diseaseskin and connective tissue diseasesImmunosuppressive AgentsGenome-Wide Association StudyAutoimmunity reviews
researchProduct

PS5:100 Patophysiological role of type i and iii interferons in systemic lupus erythematosus (sle)

2018

Systemic Lupus erythematosus (SLE) is an autoimmune disease characterised by activated autoreactive lymphocytes and autoantibodies, resulting in tissue damage in multiple organs. An important factor for the disease´s mortality is the development of Lupus nephritis (LN). Type I and III interferons, which are both part of the antiviral defense, have both been associated with the disease´s activity. In sera and urine of SLE patients an enhanced level of IL28/29 was described, but their distinct functional role in the course of disease need to be further investigated. To determine the role of type I and III interferons during onset and progression of autoimmunity – with focus on the development…

Autoimmune diseaseSystemic lupus erythematosusbusiness.industryLupus nephritisAutoantibodyGlomerulonephritisSpleenmedicine.diseasemedicine.disease_causeAutoimmunitymedicine.anatomical_structureimmune system diseasesImmunologyMedicineskin and connective tissue diseasesbusinessReceptorPoster session 5: Innate and adaptive immunity
researchProduct

Autoimmune ear disease: clinical and diagnostic relevance in Cogan’s sydrome

2017

The autoimmune inner ear disease is a clinical syndrome with uncertain pathogenesis that is often associated to rapidly progressive hearing loss that, especially at the early stages of disease, may be at monoaural localization, although more often it is at binaural localization. It usually occurs as a sudden deafness, or a rapidly progressive sensorineural hearing loss. In this study a particular form of autoimmune inner ear disease is described, Cogan’s syndrome. Cogan’s syndrome is a chronic inflammatory disorder that most commonly affects young adults. Clinical hallmarks are interstitial keratitis, vestibular and auditory dysfunction. Associations between Cogan’s syndrome and systemic va…

Autoimmune ear disordermedicine.medical_specialtyPathologyInterstitial keratitisHearing lossEar diseaseCase ReportDisease03 medical and health sciences0302 clinical medicinemedicineotorhinolaryngologic diseases030223 otorhinolaryngologyAortitis030203 arthritis & rheumatologyCogan’s syndromebusiness.industryAutoimmune inner ear diseaseHearing lossmedicine.diseaselcsh:OtorhinolaryngologyDermatologylcsh:RF1-547OtorhinolaryngologyHearing loss.Sensorineural hearing lossAutoimmune ear disorder; Cogan’s syndrome; Hearing loss.medicine.symptombusinessSystemic vasculitisAudiology Research
researchProduct

Assessing the electricity consumption of outdoor lighting systems in the presence of automatic control: The OL-BAC factors method

2020

Abstract Building automation systems are able to influence significantly buildings’ energy performance. The BAC factors method, presented for the first time by the International Standard EN 15232, is the most used and simple instrument for evaluating the impact of such systems in terms of reduction of the electrical and thermal energy consumption of buildings services. Nevertheless, Standard EN 15232 does not take into consideration the automation of lighting systems serving buildings’ external areas like passages, gardens, entrance walkways, etc. In some cases, such areas can be very extended and, as a consequence, responsible for a not negligible percentage of the overall electricity cons…

Automatic controlComputer scienceGeography Planning and Development0211 other engineering and technologiesBuilding automationTransportation02 engineering and technology010501 environmental sciences01 natural sciencesAutomotive engineeringBAC; Building automation; Energy efficiency; Outdoor lighting; Standard EN 15232021108 energy0105 earth and related environmental sciencesCivil and Structural EngineeringBuilding automationBACConsumption (economics)Settore ING-IND/11 - Fisica Tecnica AmbientaleRenewable Energy Sustainability and the Environmentbusiness.industryEnergy consumptionStandard EN 15232AutomationSettore ING-IND/33 - Sistemi Elettrici Per L'EnergiaEnergy efficiencyOutdoor lightingElectricitybusinessThermal energyEfficient energy use
researchProduct

Come valutare i risultati scolastici : modelli a confronto

2006

06079

Autonomia[SHS.SOCIO]Humanities and Social Sciences/Sociology[SHS.SOCIO] Humanities and Social Sciences/Sociology[SHS.EDU]Humanities and Social Sciences/Education[SHS.EDU] Humanities and Social Sciences/EducationAutonomie des établissements[ SHS.EDU ] Humanities and Social Sciences/EducationResultati scolastici[ SHS.SOCIO ] Humanities and Social Sciences/SociologySystème éducatifRésultat scolaireSistemi educativi
researchProduct

Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production

2011

The antimalarial agent artesunate (ART) activates programmed cell death (PCD) in cancer cells in a manner dependent on the presence of iron and the generation of reactive oxygen species. In malaria parasites, ART cytotoxicity originates from interactions with heme-derived iron within the food vacuole. The analogous digestive compartment of mammalian cells, the lysosome, similarly contains high levels of redox-active iron and in response to specific stimuli can initiate mitochondrial apoptosis. We thus investigated the role of lysosomes in ART-induced PCD and determined that in MCF-7 breast cancer cells ART activates lysosome-dependent mitochondrial outer membrane permeabilization. ART impac…

AutophagosomeProgrammed cell deathEndosomeIronArtesunateApoptosisBreast NeoplasmsMitochondrionBiologyBiochemistryPermeabilityAntimalarialsCell Line TumorLysosomemedicineHumansEnzyme InhibitorsMolecular BiologyAutophagyChloroquineCell BiologyArtemisininsMitochondriaCell biologymedicine.anatomical_structureApoptosisMitochondrial MembranesCancer cellFemaleMacrolidesLysosomesReactive Oxygen SpeciesJournal of Biological Chemistry
researchProduct